Bixiye
QP59-22 MHCP Pharmacy Benefit Update – New drug-related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Tarpeyo™ (budesonide)
Taariikhda dhaqangalka Barnaamijka: Jul 13, 2022
Natiijooyinka Raadinta
Soo bandhiga 941 - 950 ee natiijooyinka 4161
Bixiye
QP60-22 MHCP Pharmacy Benefit Exclusion for Camcevi™ (leuprolide)
Taariikhda dhaqangalka Barnaamijka: Jul 13, 2022
Bixiye
2022 July Bulletins
Taariikhda dhaqangalka Barnaamijka: Jul 01, 2022
Bixiye
P79R1-21 Notice of Admission (NOA) Claims Required for Home Care Claims Effective January 1, 2022
Taariikhda dhaqangalka Barnaamijka: Jul 01, 2022
Bixiye
P25R1-22 Update: Modifier -52, -CO and -CQ Reimbursement Changes – Effective July 1, 2022
Taariikhda dhaqangalka Barnaamijka: Jul 01, 2022
Bixiye
P37-22 Updated Minnesota Health Care Programs and Minnesota Senior Health Options (MSHO) Prior Authorization and Medical Policy Requirements
Taariikhda dhaqangalka Barnaamijka: Jul 01, 2022
Bixiye
P38-22 eviCore Healthcare Specialty Utilization Management (UM) Program: Musculoskeletal Clinical Guideline Updates
Taariikhda dhaqangalka Barnaamijka: Jul 01, 2022
Bixiye
P39-22 New Medical, Medical Drug and Behavioral Health Policy Management Updates: Effective September 5, 2022
Taariikhda dhaqangalka Barnaamijka: Jul 01, 2022
Bixiye
P40-22 Medical Policy Updates: Coupe Health and Self-Funded Benefit Plans managed by Blue Cross and Blue Shield of Alabama
Taariikhda dhaqangalka Barnaamijka: Jul 01, 2022